Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Bevacizumab × Clear all

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

186 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00027703 2014-02-11

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

106 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Clinical Trials

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

MiST

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma